Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sham Comparator Sham Aitbs

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05849402Not ApplicableActive Not Recruiting

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder

Showing all 1 trials

Research Network

Common Treatments

  • Sham Comparator Sham Aitbs1
  • Active Comparator Active Aitbs1

Active Sponsors

  • Stanford University1

Top Investigators

Related Conditions

  • Bipolar Ii Disorder Most Recent Episode Major Depressive1
  • Treatment Resistant Depression1

Activity Timeline